Miklós Szilágyi Sándor, Szilágyi L, Görög L K, Luca C T, Cozma D, Ivanica G, Benyó Z
Faculty of Technical and Human Sciences Corunca Romania, Sapientia - Hungarian Science University of Transylvania, Corunca Romania.
Acta Physiol Hung. 2011 Sep;98(3):347-58. doi: 10.1556/APhysiol.98.2011.3.12.
This paper presents an analysis of the Arruda accessory pathway localization method for patients suffering from Wolff-Parkinson-White syndrome, with modifications to increase the overall accuracy. The Arruda method was tested on a total of 79 cases, and 91.1% localization performance was reached. After a deeper analysis of each decision point of the Arruda localization method, we considered that the lead aVF was not as relevant as other leads (I, II, III, V1) used. The branch of the decision tree, which evaluates the left ventricle positions, was entirely replaced using different decision criteria based on the same biological parameters. The modified algorithm significantly improves the localization accuracy in the left ventricle, reaching 94.9%. An accurate localization performance of non-invasive methods is relevant because it can enlighten the necessary invasive interventions, and it also reduces the discomfort caused to the patient.
本文介绍了一种针对患有预激综合征患者的阿茹达附加通路定位方法的分析，并进行了改进以提高整体准确性。阿茹达方法总共在79例病例上进行了测试，定位性能达到了91.1%。在对阿茹达定位方法的每个决策点进行深入分析后，我们认为aVF导联与其他使用的导联（I、II、III、V1）相比关联性没那么强。评估左心室位置的决策树分支完全基于相同的生物学参数使用不同的决策标准进行了替换。改进后的算法显著提高了左心室的定位准确性，达到了94.9%。非侵入性方法的准确定位性能很重要，因为它可以为必要的侵入性干预提供指导，还能减轻患者的不适。
